Trials / Unknown
UnknownNCT04858308
Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 554 (estimated)
- Sponsor
- Yooyoung Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
Phase 3 study to evaluate the effiacay and safety of YYC506
Detailed description
Phase 3 study to evaluate the effiacay and safety of YYC506 in patients with complex dyslipidemia where LDL-C is properly controlled but TG and HDL-C levels are not regulated by Atorvastatin alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YYC506 | YYC506 |
| DRUG | Control | Active control |
| DRUG | YYC506 Placebo | Placebo |
| DRUG | Control Placebo | Placebo |
Timeline
- Start date
- 2021-01-29
- Primary completion
- 2021-05-31
- Completion
- 2022-01-31
- First posted
- 2021-04-26
- Last updated
- 2021-04-26
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04858308. Inclusion in this directory is not an endorsement.